Worldwide H1N1 Vaccines Market 2016 Trend, Analysis and Overview

The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.

Publisher's analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.

For more information about this report: http://www.reportsweb.com/global-h1n1-vaccines-market-2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Publisher's report, Global H1N1 Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Sanofi
- GSK
- Astra Zeneca
- CSL

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001291741/sample

Other prominent vendors
- Abbott
- Baxter International
- CEL-SCI
- Cipla
- Crucell
- Denka Seiken
- Green Cross
- Hualan Biological Engineering
- iBio
- Imunoloski Zavod
- Inovio Biomedical
- Lupin
- Medicago USA
- Merck
- Mitsubishi Tanabe Pharma
- Omnivest
- Panacea
- Pfizer
- Protein Sciences
- Serum Institute of India
- Sinovac Biotech
- Solvay
- Zhejiang Tianyuan Bio-pharmaceuticals
- Zydus Cadila

Market driver
- Global action plan for influenza vaccines
- For a full, detailed list, view our report

Market challenge
- Vaccine storage and handling issues
- For a full, detailed list, view our report

Market trend
- Improved understanding of immunology
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001291741/buying

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com